| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/20/2013 | CN102985104A Methods and systems using pharmacokinetic and pharmacodynamic profiles in interferon-alpha therapeutic regimens |
| 03/20/2013 | CN102985103A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex |
| 03/20/2013 | CN102985102A Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof |
| 03/20/2013 | CN102985101A Virally-inactivated growth factors-containing platelet lysate depleted of PDGF and VEGF and preparation method thereof |
| 03/20/2013 | CN102985100A Compositions and methods for treating COPD exacerbation |
| 03/20/2013 | CN102978277A Assays and methods using biomarkers |
| 03/20/2013 | CN102978213A Gene segment for coding swine beta interferon and application thereof |
| 03/20/2013 | CN102978185A Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 03/20/2013 | CN102977223A Preparation method for anisic aldehyde-modified sodium alginate and gel microspheres thereof |
| 03/20/2013 | CN102977215A Caspase-1 inhibitor targeting liver and application thereof |
| 03/20/2013 | CN102977205A Novel osteoprotegerin variant proteins |
| 03/20/2013 | CN102977203A Epithelial cell division chalone, and preparation method and application thereof |
| 03/20/2013 | CN102977201A Scoropendra subspinipes mutilans polypeptide toxin mu-SLPTX-Ssm6a and gene and application thereof |
| 03/20/2013 | CN102977188A GNRH (gonadotropin-releasing hormone) peptide variants |
| 03/20/2013 | CN102977186A Glycine-L-cysteine-homotaurine tripeptide and application thereof |
| 03/20/2013 | CN102973944A Preparation method of sugar-containing temperature-sensitive protein medicine carrier |
| 03/20/2013 | CN102973927A Manufacturing method of antipruritic toilet paper |
| 03/20/2013 | CN102973926A Uses of thymopeptide alpha1 in pulmonary fibrosis drug preparation |
| 03/20/2013 | CN102973925A Preparation method of composition for promoting wound healing |
| 03/20/2013 | CN102973924A Brain-tonic anti-aging Chinese patent medicine and preparation method thereof |
| 03/20/2013 | CN102973923A Compound premix for preventing and treating dairy cow mastitis recessive, and preparation method and application |
| 03/20/2013 | CN102973922A Application of fusion protein |
| 03/20/2013 | CN102973603A 转移因子胶囊 Transfer Factor Capsule |
| 03/20/2013 | CN102973526A Protective agent of human antithrombin preparation in freezing and drying process |
| 03/20/2013 | CN102973521A Poultry transfer factor nanoparticle and preparation method thereof |
| 03/20/2013 | CN102492020B Pidotimod compound and new preparation method thereof |
| 03/20/2013 | CN102430112B Atomization inhalant prepared from interferon alpha and salbutamol sulfate |
| 03/20/2013 | CN102311951B Constitutive expression cassette of Trichoderma reesei, expression vector, and recombinant strain and application thereof |
| 03/20/2013 | CN102304169B Antihypertensive polypeptide and use thereof |
| 03/20/2013 | CN102276694B Blood pressure lowering functional polypeptide from pig blood and application thereof |
| 03/20/2013 | CN102276693B Blood pressure lowering functional polypeptide from pig blood and application thereof |
| 03/20/2013 | CN102276692B Functional polypeptide and application thereof |
| 03/20/2013 | CN102276690B Blood pressure lowering functional polypeptide and application thereof |
| 03/20/2013 | CN102247603B Infusion protein with transdermal drug delivery property |
| 03/20/2013 | CN102219831B Antibiotic peptide as well as preparation method and application thereof |
| 03/20/2013 | CN102199206B Insulin analogue having quick response and stability under acidic condition and preparation thereof |
| 03/20/2013 | CN102133235B Toad peptide antibiotic medicine for treating phthisis |
| 03/20/2013 | CN102093250B Refining method of alanyl-glutamine compound |
| 03/20/2013 | CN102071184B Tabanusyao Macquart antithrombotic enzyme tablysin and gene and application thereof |
| 03/20/2013 | CN101954068B Combined medicament for treating prostatitis and preparation method thereof |
| 03/20/2013 | CN101954064B Composition for whitening and removing spots and preparation method thereof |
| 03/20/2013 | CN101928335B Fungus antitumor polypeptide nucleotide sequence, and preparation method and applications thereof |
| 03/20/2013 | CN101889023B Purification of PEGylated polypeptides |
| 03/20/2013 | CN101878849B Polypeptide powder of crocodile and preparation method and application thereof |
| 03/20/2013 | CN101869701B Hepatocyte growth-promoting factor enteric-coated capsule |
| 03/20/2013 | CN101863963B Helicobacter pylori antigen epitope polypeptide and application thereof |
| 03/20/2013 | CN101838307B K2 polypeptide synthesis product and application thereof |
| 03/20/2013 | CN101838306B K4 polypeptide synthesis product and application thereof |
| 03/20/2013 | CN101768578B Eosinophilic lactase BGALA, gene and application thereof |
| 03/20/2013 | CN101677978B Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
| 03/20/2013 | CN101543546B Antioxidative substance and composition and use thereof |
| 03/20/2013 | CN101522709B Pegylated PTH as PTH receptor modulators and uses thereof |
| 03/20/2013 | CN101420969B Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function |
| 03/20/2013 | CN101371918B Novel use of oxidation resistance dipeptide in fish extract polypeptide |
| 03/20/2013 | CN101146819B Peptides that increase collagen or hyaluronic acid production |
| 03/20/2013 | CN101111260B Survivin peptide vaccine |
| 03/19/2013 | US8399650 Mycobacterial antigens expressed during latency |
| 03/19/2013 | US8399628 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof |
| 03/19/2013 | US8399619 Injectable collagen material |
| 03/19/2013 | US8399615 Processes and intermediates |
| 03/19/2013 | US8399611 Template-fixed peptidomimetics |
| 03/19/2013 | US8399609 Treating or preventing extracellular matrix build-up |
| 03/19/2013 | US8399417 Food |
| 03/19/2013 | US8399416 Method of using heparin binding motif for treating asthma |
| 03/19/2013 | US8399415 Oligopeptides and cosmetic compositions containing the oligopeptides |
| 03/19/2013 | US8399414 Analgesics |
| 03/19/2013 | US8399412 Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating NF-kappabeta or supressing NF-kappabeta-mediated actions |
| 03/19/2013 | US8399411 Composition for animal consumption and method for reducing MAP kinase activity |
| 03/19/2013 | US8399410 Methods and devices for desmopressin drug delivery |
| 03/19/2013 | US8399409 Compositions and methods for arthrodetic procedures |
| 03/19/2013 | US8399408 Method for treating diabetes using neurturin |
| 03/19/2013 | US8399407 Non-standard insulin analogues |
| 03/19/2013 | US8399406 Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C) |
| 03/19/2013 | US8399405 Peptidomimetic macrocycles |
| 03/19/2013 | US8399404 Methods and uses for inhibiting platelet coagulation |
| 03/19/2013 | US8399403 drug-ligand conjugates that are potent cytotoxins; stabilized therapeutic agents and markers; exhibit high specificity of action, reduced toxicity, and improved stability in blood ; antitumors |
| 03/19/2013 | US8399402 Polypeptide as standard for proteome analysis |
| 03/19/2013 | US8399233 Histone deacetylases, and uses related thereto |
| 03/19/2013 | US8399223 Composition containing arazyme for the prevention and treatment of cancer |
| 03/19/2013 | US8399219 Protease activatable interferon alpha proprotein |
| 03/19/2013 | US8399211 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 03/19/2013 | US8399203 Analysis of chemically crosslinked cellular samples |
| 03/19/2013 | US8399201 Polypeptide complex of TRPM8 and calmodulin and its uses thereof |
| 03/19/2013 | US8399014 Physiologically active complex comprising protamine and/or salt therefor and an acidic macromolecular substance, and use thereof |
| 03/19/2013 | US8399010 Highly-mineralized osteogenic sponge compositions and uses thereof |
| 03/19/2013 | US8398998 Therapeutic composition comprising a botulinum neurotoxin |
| 03/19/2013 | US8398996 Staphylococcus aureus proteins and nucleic acids |
| 03/19/2013 | US8398990 Glucan-based vaccines |
| 03/19/2013 | US8398984 Removal promoters and inhibitor for apoptosis cells in vivo |
| 03/19/2013 | US8398972 Methods of treating dementia using a GM-CSF antagonist |
| 03/19/2013 | US8398971 Methods, compounds, and compositions for treatment and prophylaxis in the respiratory tract |
| 03/19/2013 | US8398967 Particle formulations for use in pharmaceutical compositions |
| 03/19/2013 | CA2719531C New ruthenium complexes as catalysts for metathesis reactions |
| 03/19/2013 | CA2556227C Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
| 03/19/2013 | CA2534313C Formulations containing an immune response modifier |
| 03/19/2013 | CA2513251C Cancer therapy sensitizer |
| 03/19/2013 | CA2500248C Peptide derivative fusion inhibitors of hiv infection |
| 03/19/2013 | CA2491907C Oncolytic virus replicating selectively in tumor cells |
| 03/19/2013 | CA2367901C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 03/19/2013 | CA2354638C Expression of secreted human alpha-fetoprotein in transgenic animals |